Neogen Corp SEC filings NEOG
Neogen Corp has 1,000 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Aug 21, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 7, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 26, 2026 | Oct 1, 2026 |
| S-8 | Employee stock plan registration | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Oct 20, 2026 | — |
| 10-Q | Quarterly report | Oct 7, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 7, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 6, 2026 | Oct 6, 2026 |
| DEFA14A | Additional proxy material | Sep 28, 2026 | — |
| ARS | Annual report to shareholders | Aug 21, 2026 | May 31, 2026 |
| DEFA14A | Additional proxy material | Aug 21, 2026 | — |
| DEF 14A | Proxy statement | Aug 21, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2026 | Aug 3, 2026 |
| 10-K | Annual report | Jul 30, 2026 | May 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 11-K | Employee savings plan report | Jun 25, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 20, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| 10-Q | Quarterly report | Apr 9, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-Q | Quarterly report | Jan 8, 2026 | Nov 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 28, 2025 | Aug 14, 2025 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 27, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 27, 2025 | Oct 23, 2025 |
| 10-Q | Quarterly report | Oct 9, 2025 | Aug 31, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 9, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 15, 2025 | Sep 12, 2025 |
| ARS | Annual report to shareholders | Sep 12, 2025 | May 31, 2025 |
| DEFA14A | Additional proxy material | Sep 12, 2025 | — |
| DEF 14A | Proxy statement | Sep 12, 2025 | Sep 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-K | Annual report | Jul 30, 2025 | May 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| 11-K | Employee savings plan report | Jun 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2025 | Apr 22, 2025 |
| 10-Q | Quarterly report | Apr 9, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 7, 2025 | Apr 4, 2025 |
| 10-Q | Quarterly report | Jan 15, 2025 | Nov 30, 2024 |
| NT 10-Q | Filing | Jan 10, 2025 | Nov 30, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 17, 2024 | Sep 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 28, 2024 | Oct 24, 2024 |
| 10-Q | Quarterly report | Oct 10, 2024 | Aug 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2024 | Oct 10, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 10, 2024 | Oct 10, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 1, 2024 | Sep 25, 2024 |
| DEF 14A | Proxy statement | Sep 13, 2024 | Oct 24, 2024 |
| ARS | Annual report to shareholders | Sep 13, 2024 | May 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2024 | Sep 5, 2024 |
| S-8 | Employee stock plan registration | Aug 20, 2024 | — |
| S-8 | Employee stock plan registration | Aug 20, 2024 | — |
| 10-K | Annual report | Jul 30, 2024 | May 31, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2024 | Jul 30, 2024 |
| 11-K | Employee savings plan report | Jun 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2024 | Jun 4, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2024 | — |
| 10-Q | Quarterly report | Apr 9, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 5, 2024 | Apr 1, 2024 |
| 10-Q | Quarterly report | Jan 9, 2024 | Nov 30, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Oct 31, 2023 | Oct 25, 2023 |
| 10-Q | Quarterly report | Oct 10, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 10, 2023 | Oct 10, 2023 |
| DEF 14A | Proxy statement | Sep 18, 2023 | Oct 25, 2023 |
| ARS | Annual report to shareholders | Sep 18, 2023 | May 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 7, 2023 | Sep 7, 2023 |
| 10-K | Annual report | Aug 15, 2023 | May 31, 2023 |
| NT 10-K | Filing | Jul 31, 2023 | May 31, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2023 | Jul 27, 2023 |
| 11-K | Employee savings plan report | Jun 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2023 | Jun 6, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2023 | Apr 6, 2023 |
| 10-Q | Quarterly report | Apr 4, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 10-Q | Quarterly report | Jan 9, 2023 | Nov 30, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 5, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Oct 7, 2022 | Oct 6, 2022 |
| 10-Q | Quarterly report | Sep 30, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Results of operations
|
Sep 28, 2022 | Sep 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2022 | Sep 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2022 | Sep 2, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, New debt, Bylaw or fiscal year change, Other events
|
Sep 1, 2022 | Sep 1, 2022 |
| DEF 14A | Proxy statement | Aug 30, 2022 | Oct 6, 2022 |
| 425 | Filing | Aug 18, 2022 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Aug 18, 2022 | Aug 17, 2022 |
| 425 | Filing | Aug 17, 2022 | — |
| 425 | Filing | Aug 12, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2022 | Aug 12, 2022 |
| 425 | Filing | Aug 5, 2022 | — |
| 8-K |
Current report
Other events
|
Aug 5, 2022 | Aug 5, 2022 |
| SEC STAFF LETTER | Filing | Aug 4, 2022 | — |
| EFFECT | Filing | Aug 4, 2022 | — |
| 424B3 | Prospectus | Aug 4, 2022 | — |
| S-4/A | Filing | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Aug 2, 2022 | — |
| CORRESP | Letter to the SEC | Aug 1, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| 8-K |
Current report
Results of operations
|
Jul 27, 2022 | Jul 26, 2022 |
| S-4/A | Filing | Jul 27, 2022 | — |
| 10-K | Annual report | Jul 27, 2022 | May 31, 2022 |
| DEFM14A | Filing | Jul 18, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2022 | — |
| PRER14A | Filing | Jul 13, 2022 | — |
| SEC STAFF LETTER | Filing | Jul 11, 2022 | — |
| 425 | Filing | Jul 7, 2022 | — |
| 8-K |
Current report
Other events
|
Jul 7, 2022 | Jul 7, 2022 |
| PRER14A | Filing | Jul 1, 2022 | — |
| CORRESP | Letter to the SEC | Jul 1, 2022 | — |
| S-4/A | Filing | Jul 1, 2022 | — |
| 11-K | Employee savings plan report | Jun 27, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2022 | — |
| CORRESP | Letter to the SEC | Jun 9, 2022 | — |
| PRER14A | Filing | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | Jun 8, 2022 | — |
| S-4/A | Filing | Jun 8, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| CORRESP | Letter to the SEC | May 6, 2022 | — |
| PRER14A | Filing | May 6, 2022 | — |
| S-4/A | Filing | May 5, 2022 | — |
| CORRESP | Letter to the SEC | May 4, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2022 | Apr 19, 2022 |
| 425 | Filing | Apr 21, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2022 | — |
| 10-Q | Quarterly report | Apr 1, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2022 | Mar 24, 2022 |
| PREM14A | Filing | Mar 18, 2022 | Mar 18, 2022 |
| S-4 | Registration for a merger or exchange | Mar 17, 2022 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 17, 2022 | Mar 14, 2022 |
| 425 | Form 425 | Mar 11, 2022 | — |
| 10-Q | Quarterly report | Dec 30, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Results of operations
|
Dec 22, 2021 | Dec 21, 2021 |
| 425 | Filing | Dec 15, 2021 | — |
| 8-K |
Current report
Material agreement
|
Dec 15, 2021 | Dec 13, 2021 |
| 425 | Filing | Dec 15, 2021 | — |
| 425 | Filing | Dec 15, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 425 | Filing | Dec 14, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 3, 2021 | Dec 1, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Oct 8, 2021 | Oct 7, 2021 |
| 10-Q | Quarterly report | Sep 30, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 22, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Acquisition or sale of assets
|
Sep 22, 2021 | Sep 20, 2021 |
| DEF 14A | Proxy statement | Aug 31, 2021 | Oct 7, 2021 |
| PRE 14A | Preliminary proxy statement | Aug 19, 2021 | Oct 7, 2021 |
| 10-K | Annual report | Jul 30, 2021 | May 31, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 21, 2021 | Jul 20, 2021 |
| 11-K | Employee savings plan report | Jun 24, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| 8-K |
Current report
Other events
|
May 12, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | Mar 31, 2021 | Feb 28, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jan 7, 2021 | Jan 4, 2021 |
| 10-Q | Quarterly report | Dec 29, 2020 | Nov 30, 2020 |
| 8-K |
Current report
Results of operations
|
Dec 22, 2020 | Dec 22, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 17, 2020 | Nov 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Oct 9, 2020 | Oct 8, 2020 |
| 10-Q | Quarterly report | Sep 30, 2020 | Aug 31, 2020 |
| 8-K |
Current report
Results of operations
|
Sep 23, 2020 | Sep 22, 2020 |
| DEF 14A | Proxy statement | Aug 31, 2020 | Oct 8, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2020 | Aug 17, 2020 |
| 10-K | Annual report | Jul 30, 2020 | May 31, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 21, 2020 | Jul 21, 2020 |
| 11-K | Employee savings plan report | Jun 26, 2020 | Dec 31, 2019 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Apr 14, 2020 | Apr 10, 2020 |
| 10-Q | Quarterly report | Apr 3, 2020 | Feb 29, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2020 | Mar 24, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Other events
|
Dec 27, 2019 | Dec 27, 2019 |
| 10-Q | Quarterly report | Dec 27, 2019 | Nov 30, 2019 |
| 8-K |
Current report
Results of operations
|
Dec 23, 2019 | Dec 23, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Oct 7, 2019 | Oct 3, 2019 |
| 8-K |
Current report
Other events
|
Oct 2, 2019 | Oct 1, 2019 |
| 10-Q | Quarterly report | Sep 26, 2019 | Aug 31, 2019 |
| DEF 14A | Proxy statement | Aug 27, 2019 | Oct 3, 2019 |
| 10-K | Annual report | Jul 30, 2019 | May 31, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2019 | Jul 23, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- NEOG (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- MI
- Headquarters
- Lansing, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 711377
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.